-
1
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
10.1056/NEJMra011775
-
Angulo P, (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231. doi:10.1056/NEJMra011775. PubMed: 11961152.
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
2
-
-
33644547706
-
Nonalcoholic fatty liver disease: from steatosis to cirrhosis
-
10.1002/hep.20973
-
Farrell GC, Larter CZ, (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112. doi:10.1002/hep.20973. PubMed: 16447287.
-
(2006)
Hepatology
, vol.43
-
-
Farrell, G.C.1
Larter, C.Z.2
-
3
-
-
84859404868
-
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications
-
e716 10.1053/j.gastro.2012.02.003
-
Cusi K, (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142: 711-725 e716 doi:10.1053/j.gastro.2012.02.003. PubMed: 22326434.
-
(2012)
Gastroenterology
, vol.142
, pp. 711-725
-
-
Cusi, K.1
-
4
-
-
77957746634
-
Roles of liver innate immune cells in nonalcoholic fatty liver disease
-
10.3748/wjg.v16.i37.4652
-
Zhan YT, An W, (2010) Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 16: 4652-4660. doi:10.3748/wjg.v16.i37.4652. PubMed: 20872965.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 4652-4660
-
-
Zhan, Y.T.1
An, W.2
-
5
-
-
84866107224
-
Lymphocytes in obesity-related adipose tissue inflammation
-
10.1007/s00125-012-2607-0
-
Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T, (2012) Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 55: 2583-2592. doi:10.1007/s00125-012-2607-0. PubMed: 22733483.
-
(2012)
Diabetologia
, vol.55
, pp. 2583-2592
-
-
Chatzigeorgiou, A.1
Karalis, K.P.2
Bornstein, S.R.3
Chavakis, T.4
-
6
-
-
0348230958
-
Obesity is associated with macrophage accumulation in adipose tissue
-
10.1172/JCI19246
-
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808. doi:10.1172/JCI19246. PubMed: 14679176.
-
(2003)
J Clin Invest
, vol.112
, pp. 1796-1808
-
-
Weisberg, S.P.1
McCann, D.2
Desai, M.3
Rosenbaum, M.4
Leibel, R.L.5
-
7
-
-
84863098121
-
Inflammation and fibrogenesis in steatohepatitis
-
10.1007/s00535-012-0527-x
-
Fujii H, Kawada N, (2012) Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol 47: 215-225. doi:10.1007/s00535-012-0527-x. PubMed: 22310735.
-
(2012)
J Gastroenterol
, vol.47
, pp. 215-225
-
-
Fujii, H.1
Kawada, N.2
-
8
-
-
84864776540
-
Indoleamine 2,3-dioxygenase: from catalyst to signaling function
-
10.1002/eji.201242572
-
Fallarino F, Grohmann U, Puccetti P, (2012) Indoleamine 2,3-dioxygenase: from catalyst to signaling function. Eur J Immunol 42: 1932-1937. doi:10.1002/eji.201242572. PubMed: 22865044.
-
(2012)
Eur J Immunol
, vol.42
, pp. 1932-1937
-
-
Fallarino, F.1
Grohmann, U.2
Puccetti, P.3
-
9
-
-
0037136328
-
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
-
10.1084/jem.20020121
-
Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, et al. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196: 459-468. doi:10.1084/jem.20020121. PubMed: 12186838.
-
(2002)
J Exp Med
, vol.196
, pp. 459-468
-
-
Frumento, G.1
Rotondo, R.2
Tonetti, M.3
Damonte, G.4
Benatti, U.5
-
10
-
-
5044220930
-
IDO expression by dendritic cells: tolerance and tryptophan catabolism
-
10.1038/nri1457
-
Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774. doi:10.1038/nri1457. PubMed: 15459668.
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 762-774
-
-
Mellor, A.L.1
Munn, D.H.2
-
11
-
-
79957936035
-
Indoleamine 2,3-dioxygenase, Tregs and cancer
-
10.2174/092986711795656045
-
Munn DH, (2011) Indoleamine 2,3-dioxygenase, Tregs and cancer. Curr Med Chem 18: 2240-2246. doi:10.2174/092986711795656045. PubMed: 21517755.
-
(2011)
Curr Med Chem
, vol.18
, pp. 2240-2246
-
-
Munn, D.H.1
-
12
-
-
77952575494
-
Pathology of immune-mediated liver injury
-
10.1159/000282065
-
Dienes HP, Drebber U, (2010) Pathology of immune-mediated liver injury. Dig Dis 28: 57-62. doi:10.1159/000282065. PubMed: 20460891.
-
(2010)
Dig Dis
, vol.28
, pp. 57-62
-
-
Dienes, H.P.1
Drebber, U.2
-
13
-
-
31044446342
-
Monitoring tryptophan metabolism in chronic immune activation
-
10.1016/j.cca.2005.06.013
-
Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D, (2006) Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364: 82-90. doi:10.1016/j.cca.2005.06.013. PubMed: 16139256.
-
(2006)
Clin Chim Acta
, vol.364
, pp. 82-90
-
-
Schröcksnadel, K.1
Wirleitner, B.2
Winkler, C.3
Fuchs, D.4
-
14
-
-
33947434850
-
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection
-
10.1128/JVI.02248-06
-
Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, et al. (2007) Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection. J Virol 81: 3662-3666. doi:10.1128/JVI.02248-06. PubMed: 17229698.
-
(2007)
J Virol
, vol.81
, pp. 3662-3666
-
-
Larrea, E.1
Riezu-Boj, J.I.2
Gil-Guerrero, L.3
Casares, N.4
Aldabe, R.5
-
15
-
-
84878115181
-
Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection
-
22976933
-
Higashitani K, Kanto T, Kuroda S, Yoshio S, Matsubara T, et al. (2012) Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection. J Gastroenterol, 48: 660-70. PubMed: 22976933.
-
(2012)
J Gastroenterol
, vol.48
, pp. 660-670
-
-
Higashitani, K.1
Kanto, T.2
Kuroda, S.3
Yoshio, S.4
Matsubara, T.5
-
16
-
-
84863888349
-
Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone
-
10.1152/ajpregu.00373.2011
-
Wolowczuk I, Hennart B, Leloire A, Bessede A, Soichot M, et al. (2012) Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regul Integr Comp Physiol 303: R135-R143. doi:10.1152/ajpregu.00373.2011. PubMed: 22592557.
-
(2012)
Am J Physiol Regul Integr Comp Physiol
, vol.303
-
-
Wolowczuk, I.1
Hennart, B.2
Leloire, A.3
Bessede, A.4
Soichot, M.5
-
17
-
-
58149489295
-
Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo
-
10.1111/j.1478-3231.2008.01748.x
-
Iwamoto N, Ito H, Ando K, Ishikawa T, Hara A, et al. (2009) Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo. Liver Int 29: 277-283. doi:10.1111/j.1478-3231.2008.01748.x. PubMed: 18397228.
-
(2009)
Liver Int
, vol.29
, pp. 277-283
-
-
Iwamoto, N.1
Ito, H.2
Ando, K.3
Ishikawa, T.4
Hara, A.5
-
18
-
-
78049522618
-
Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model
-
10.4049/jimmunol.0904173
-
Ito H, Hoshi M, Ohtaki H, Taguchi A, Ando K, et al. (2010) Ability of IDO to attenuate liver injury in alpha-galactosylceramide-induced hepatitis model. J Immunol 185: 4554-4560. doi:10.4049/jimmunol.0904173. PubMed: 20844202.
-
(2010)
J Immunol
, vol.185
, pp. 4554-4560
-
-
Ito, H.1
Hoshi, M.2
Ohtaki, H.3
Taguchi, A.4
Ando, K.5
-
19
-
-
84862789890
-
Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats
-
10.1002/cbf.2803
-
Li D, Cai H, Hou M, Fu D, Ma Y, et al. (2012) Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats. Cell Biochem Funct 30: 309-314. doi:10.1002/cbf.2803. PubMed: 22249930.
-
(2012)
Cell Biochem Funct
, vol.30
, pp. 309-314
-
-
Li, D.1
Cai, H.2
Hou, M.3
Fu, D.4
Ma, Y.5
-
20
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
10.1002/hep.20701
-
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321. doi:10.1002/hep.20701. PubMed: 15915461.
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
-
21
-
-
84870348582
-
Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice
-
23027617
-
Terakura D, Shimizu M, Iwasa J, Baba A, Kochi T, et al. (2012) Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Carcinogenesis, 33: 2499-506. PubMed: 23027617.
-
(2012)
Carcinogenesis
, vol.33
, pp. 2499-2506
-
-
Terakura, D.1
Shimizu, M.2
Iwasa, J.3
Baba, A.4
Kochi, T.5
-
22
-
-
70350130982
-
(-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R
-
10.1016/j.cbi.2009.07.015
-
Yasuda Y, Shimizu M, Sakai H, Iwasa J, Kubota M, et al. (2009) (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R. Chem Biol Interact 182: 159-164. doi:10.1016/j.cbi.2009.07.015. PubMed: 19646978.
-
(2009)
Chem Biol Interact
, vol.182
, pp. 159-164
-
-
Yasuda, Y.1
Shimizu, M.2
Sakai, H.3
Iwasa, J.4
Kubota, M.5
-
23
-
-
84862808949
-
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase
-
10.1111/j.1349-7006.2012.02237.x
-
Ogawa K, Hara T, Shimizu M, Ninomiya S, Nagano J, et al. (2012) Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase. Cancer Sci 103: 951-958. doi:10.1111/j.1349-7006.2012.02237.x. PubMed: 22320717.
-
(2012)
Cancer Sci
, vol.103
, pp. 951-958
-
-
Ogawa, K.1
Hara, T.2
Shimizu, M.3
Ninomiya, S.4
Nagano, J.5
-
24
-
-
79954567178
-
Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
-
10.1586/egh.11.16
-
Machado MV, Cortez-Pinto H, (2011) Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? Expert Rev Gastroenterol Hepatol 5: 213-222. doi:10.1586/egh.11.16. PubMed: 21476916.
-
(2011)
Expert Rev Gastroenterol Hepatol
, vol.5
, pp. 213-222
-
-
Machado, M.V.1
Cortez-Pinto, H.2
-
25
-
-
84859445823
-
TGF-beta in progression of liver disease
-
10.1007/s00441-011-1246-y
-
Dooley S, ten Dijke P, (2012) TGF-beta in progression of liver disease. Cell Tissue Res 347: 245-256. doi:10.1007/s00441-011-1246-y. PubMed: 22006249.
-
(2012)
Cell Tissue Res
, vol.347
, pp. 245-256
-
-
Dooley, S.1
ten Dijke, P.2
-
26
-
-
16244386213
-
Regulatory T cells and the liver: a new piece of the puzzle
-
10.1002/hep.20678
-
Chang KM, (2005) Regulatory T cells and the liver: a new piece of the puzzle. Hepatology 41: 700-702. doi:10.1002/hep.20678. PubMed: 15789365.
-
(2005)
Hepatology
, vol.41
, pp. 700-702
-
-
Chang, K.M.1
-
27
-
-
36349010120
-
A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury
-
10.1002/hep.21823
-
Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R, et al. (2007) A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46: 1519-1529. doi:10.1002/hep.21823. PubMed: 17661402.
-
(2007)
Hepatology
, vol.46
, pp. 1519-1529
-
-
Ma, X.1
Hua, J.2
Mohamood, A.R.3
Hamad, A.R.4
Ravi, R.5
-
28
-
-
33646856421
-
Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients
-
10.1381/096089206776945066
-
Brandacher G, Winkler C, Aigner F, Schwelberger H, Schroecksnadel K, et al. (2006) Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obes Surg 16: 541-548. doi:10.1381/096089206776945066. PubMed: 16687019.
-
(2006)
Obes Surg
, vol.16
, pp. 541-548
-
-
Brandacher, G.1
Winkler, C.2
Aigner, F.3
Schwelberger, H.4
Schroecksnadel, K.5
-
29
-
-
80053433530
-
L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin
-
10.1074/jbc.M111.235473
-
Osawa Y, Kanamori H, Seki E, Hoshi M, Ohtaki H, et al. (2011) L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. J Biol Chem 286: 34800-34808. doi:10.1074/jbc.M111.235473. PubMed: 21841000.
-
(2011)
J Biol Chem
, vol.286
, pp. 34800-34808
-
-
Osawa, Y.1
Kanamori, H.2
Seki, E.3
Hoshi, M.4
Ohtaki, H.5
-
30
-
-
33644772843
-
Cryptogenic cirrhosis and NAFLD: are they related?
-
10.1111/j.1572-0241.2006.00478.x
-
Maheshwari A, Thuluvath PJ, (2006) Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol 101: 664-668. doi:10.1111/j.1572-0241.2006.00478.x. PubMed: 16464222.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 664-668
-
-
Maheshwari, A.1
Thuluvath, P.J.2
-
31
-
-
77950862594
-
NASH and cryptogenic cirrhosis: a histological analysis
-
20009134
-
Caldwell SH, Lee VD, Kleiner DE, Al-Osaimi AM, Argo CK, et al. (2009) NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol 8: 346-352. PubMed: 20009134.
-
(2009)
Ann Hepatol
, vol.8
, pp. 346-352
-
-
Caldwell, S.H.1
Lee, V.D.2
Kleiner, D.E.3
Al-Osaimi, A.M.4
Argo, C.K.5
-
32
-
-
84859444880
-
Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues
-
10.1053/j.gastro.2011.12.044
-
Hernández-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, et al. (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142: 938-946. doi:10.1053/j.gastro.2011.12.044. PubMed: 22240484.
-
(2012)
Gastroenterology
, vol.142
, pp. 938-946
-
-
Hernández-Gea, V.1
Ghiassi-Nejad, Z.2
Rozenfeld, R.3
Gordon, R.4
Fiel, M.I.5
|